Abstract
A new study in Nature has identified a small molecule inhibitor for the oncogenic Wnt/β-catenin pathway that is responsible for many human cancers. This inhibitor targets an unsuspected cellular enzyme, Tankyrase, which controls the destruction of a β-catenin destructor.
| Original language | English |
|---|---|
| Pages (from-to) | 70-73 |
| Number of pages | 4 |
| Journal | Journal of Molecular Cell Biology |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2010 |
Funding
| Funders | Funder number |
|---|---|
| National Institute of General Medical Sciences | R01GM074241 |
ASJC Scopus subject areas
- General Medicine